MELAIU, OMBRETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.834
AS - Asia 1.411
EU - Europa 1.077
SA - Sud America 254
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.608
Nazione #
US - Stati Uniti d'America 1.800
SG - Singapore 642
IT - Italia 411
BR - Brasile 219
CN - Cina 205
HK - Hong Kong 202
RU - Federazione Russa 186
VN - Vietnam 141
IE - Irlanda 119
JP - Giappone 76
DE - Germania 75
FI - Finlandia 74
NL - Olanda 58
GB - Regno Unito 49
IN - India 32
FR - Francia 28
ID - Indonesia 18
AT - Austria 16
BD - Bangladesh 16
CA - Canada 16
MX - Messico 14
AR - Argentina 13
ES - Italia 13
IQ - Iraq 11
TR - Turchia 11
EC - Ecuador 10
PL - Polonia 9
SE - Svezia 9
ZA - Sudafrica 8
MA - Marocco 7
KR - Corea 6
MY - Malesia 6
PH - Filippine 6
TH - Thailandia 6
UA - Ucraina 5
UZ - Uzbekistan 5
AL - Albania 4
CO - Colombia 4
CZ - Repubblica Ceca 4
PK - Pakistan 4
CL - Cile 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
EG - Egitto 2
GI - Gibilterra 2
HN - Honduras 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
VE - Venezuela 1
Totale 4.608
Città #
Singapore 379
San Jose 228
Hong Kong 201
Rome 151
Chandler 146
Dublin 119
Ashburn 101
New York 94
Beijing 81
Los Angeles 74
Tokyo 71
Council Bluffs 70
Santa Clara 57
Wilmington 57
The Dalles 55
Buffalo 40
Helsinki 40
Chicago 37
Ho Chi Minh City 37
Hanoi 36
Fairfield 34
São Paulo 31
Lappeenranta 28
Moscow 28
Ann Arbor 26
Milan 22
Colorado Springs 18
Frankfurt am Main 18
Houston 18
London 17
Munich 17
Salt Lake City 17
Dallas 16
Indianapolis 16
Medford 16
Brooklyn 15
Jakarta 12
Lauterbourg 12
Seattle 12
Atlanta 10
Da Nang 10
Elk Grove Village 10
Nuremberg 10
Tampa 10
Vienna 10
Woodbridge 10
Würzburg 10
Amsterdam 9
Genoa 9
Redondo Beach 9
Lawrence 8
Montreal 8
Orem 8
Cambridge 7
Chennai 7
Mülheim 7
Bangkok 6
Belo Horizonte 6
Boardman 6
Des Moines 6
Engelhard 6
Haiphong 6
Lancaster 6
Manchester 6
North Bergen 6
Phoenix 6
San Diego 6
Seoul 6
Warsaw 6
Boston 5
Guangzhou 5
Hounslow 5
Miami 5
Naples 5
Quito 5
Rio de Janeiro 5
Stockholm 5
Bologna 4
Center 4
Denver 4
Fortaleza 4
Hyderabad 4
Johannesburg 4
Manila 4
Marseille 4
Monte Vista 4
Mumbai 4
New Delhi 4
Newark 4
Nha Trang 4
Tashkent 4
Tirana 4
Toronto 4
Torrita di Siena 4
Turin 4
Turku 4
Amman 3
Baghdad 3
Bauru 3
Belgrade 3
Totale 2.805
Nome #
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 164
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of beta TrCP 160
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 154
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 141
Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma 140
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 137
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma 134
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 111
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 111
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 98
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 91
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 90
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 88
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 84
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 80
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 79
Neoadjuvant Treatment as a Risk Factor for Variation of Upper Limb Lymph Node Drainage During Axillary Reverse Mapping in Breast Cancer: A Prospective Observational Study 79
Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors 78
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis 76
The genetic susceptibility in the development of malignant pleural mesothelioma 76
Identification of overexpressed genes in malignant pleural mesothelioma 76
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 76
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment 76
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. 74
Quantification of the immune content in neuroblastoma: Deep learning and topological data analysis in digital pathology 72
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 72
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 72
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 71
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 71
ERAP1 and ERAP2 enzymes: A protective shield for ras against COVID-19? 69
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 69
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 69
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma 68
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 67
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 67
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 67
A Novel Panel of Serum Biomarkers for MPM Diagnosis 66
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy 64
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 64
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 64
Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 62
Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 60
Expression status of candidate genes in mesothelioma tissues and cell lines 59
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma 58
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma 58
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing 57
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays 57
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 56
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 56
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) 54
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme 52
Impact of natural occurring erap1 single nucleotide polymorphisms within mirna-binding sites on hcmv infection 52
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 52
Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases 51
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 51
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 51
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity 48
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24 47
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy 43
The regulatory roles of phosphatases in cancer 40
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 39
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors 38
Correction: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 29
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 28
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade 27
Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma 24
Editorial: Community series in cell network in antitumor immunity of pediatric and adult solid tumors, volume II 21
Totale 4.835
Categoria #
all - tutte 27.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 10 4
2021/202287 27 6 1 0 0 9 5 3 6 3 4 23
2022/2023503 8 7 44 48 52 118 60 28 56 15 57 10
2023/2024247 27 16 20 6 35 62 12 7 12 19 4 27
2024/20251.410 21 214 133 103 45 199 84 43 87 93 282 106
2025/20262.431 217 117 222 186 253 92 471 284 341 245 3 0
Totale 4.835